In the model of mouse inflammatory bowel diseases (IBD), CGA showed a dose-dependent decrease in expression and nuclear translocation of the NF-κB subunit, which was accompanied by the suppression of systemic inflammation in mice with colitis [45]. This evidence concerns the gene NFKB1 and colitis.